Shenzhen - Delayed Quote CNY
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (002399.SZ)
11.08
+0.05
+(0.45%)
At close: 3:04:30 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cash Flows from Used in Operating Activities Direct
1,857,710.29
2,194,132.24
398,215.68
-756,612.53
-6,629.32
Operating Cash Flow
--
2,194,132.24
398,215.68
-756,612.53
-6,629.32
Investing Cash Flow
-803,288.47
-415,048.19
1,221,569.30
249,839.60
719,928.13
Financing Cash Flow
-1,446,294.46
-2,139,730.08
-1,210,172.08
329,564.16
-501,080.67
End Cash Position
1,716,510.95
1,421,826.83
1,765,644.71
1,319,707.19
1,479,633.43
Capital Expenditure
-183,357.52
-202,769.17
-444,877.66
-222,421.48
-193,860.67
Issuance of Debt
2,610,330.75
2,686,768.82
5,109,367.27
6,755,937.62
3,693,770.05
Repayment of Debt
-3,914,452.17
-4,653,202.79
-5,991,710.83
-6,036,257.92
-3,730,561.54
Free Cash Flow
1,674,352.77
1,991,363.07
-46,661.98
-979,034
-200,489.99
12/31/2021 - 5/6/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade